@article{ATM24361,
author = {Makito Miyake and Takuya Owari and Nobumich Tanaka and Kiyohide Fujimoto},
title = {Potential biological and clinical benefit of prostate-directed interventions in patients with metastatic prostate cancer},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {In a recent issue of the Lancet, Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators, Parker et al. (1) reported the updated results of a large prospective randomized control trial (RCT) that attempted to compare the additional radiotherapy with androgen deprivation therapy (ADT) and docetaxel for metastatic prostate cancer (mPCa).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24361}
}